维普中文期刊产品整合服务
7篇 您的检索式:作者名="Llor Xavier"
    题名 作者 年代 出处 被引量
1Detection of BRAF V600E Mutation in Colorectal Cancer显示文摘Susana Benlloch Artemio Payá Cristina Alenda Xavier Bessa Montserrat Andreu Rodrigo Jover Antoni Castells Xavier Llor F. Ignacio Aranda Bartomeu Massutí 2006The Journal of Molecular Diagnostics2006,,5:1
2Computer Aided Diagnosis with Case-based Reasoning and Genetic Algorithms显示文摘Elisabet Golobardes Xavier Llorà Maria Salamó Joan Martí 2002Knowledge-Based Systems2002,,15:1
3Computer aided diagnosis with case-based reasoning and genetic algorithms显示文摘 Llor Xavier Salam Maria 2002Knowledge-Based Systems2002,15,12:1
4Aberrant DNA Methylation in Hereditary Nonpolyposis Colorectal Cancer Without Mismatch Repair Deficiency显示文摘Ajay Goel Rosa M. Xicola Thuy–Phuong Nguyen Brian J. Doyle Vanessa R. Sohn Prathap Bandipalliam Laura S. Rozek Josep Reyes Carmen Cordero Francesc Balaguer Antoni Castells Rodrigo Jover Montserrat Andreu Sapna Syngal C. Richard Boland Xavier Llor 2010Gastroenterology2010,,5:1
5Computer Aided Diagnosis with Case-Based Reasoning and Genetic Algorithms显示文摘Golobardes Elisabet Llorà Xavier Salam6 Maria 2002Knowledge-Based Systems2002,15,12:1
6The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status显示文摘Rodrigo Jover Pedro Zapater Antoni Castells Xavier Llor Montserrat Andreu Joaquín Cubiella Francesc Balaguer Laura Sempere Rosa M. Xicola Luis Bujanda Josep M. Re?é Juan Clofent Xavier Bessa Juan D. Morillas David Nicolás-Pérez Elisenda Pons Artemio Payá 2008European Journal of Cancer2008,,3:1
7Colorectal cancer prognosis twenty years later显示文摘AIM:To evaluate changes in colorectal cancer(CRC) survival over the last 20 years.METHODS:We compared two groups of consecutive CRC patients that were prospectively recruited:Group Ⅰincluded 1990 patients diagnosed between 1980 and 1994.GroupⅡincluded 871 patients diagnosed in 2001.RESULTS:The average follow up time was 21 mo(1-229)for GroupⅠand 50 mo(1-73.4)for GroupⅡ.Overall median survival was significantly longer in Group Ⅱthan in GroupⅠ(73 mo vs 25 mo,P<0.001)and the difference was significant for all tumor stages.Post surgical mortality was 8% for GroupⅠand 2% for Group Ⅱ(P<0.001).Only 17% of GroupⅠpatients received chemotherapy compared with 50% of GroupⅡpatients(P<0.001).CONCLUSION:Survival in colorectal cancer patients has doubled over the past 20 years.This increase seems to be partly due to the generalization in the administration of chemotherapy and to the decrease of post surgical mortality.Luis Bujanda Cristina Sarasqueta Elisabeth Hijona Lander Hijona Angel Cosme Ines Gil Jose Luis Elorza Jose I Asensio Santiago Larburu José M Enríquez-Navascués Rodrigo Jover Francesc Balaguer Xavier Llor Xavier Bessa Montserrat Andreu Artemio Paya Antoni Castells Gastrointestinal Oncology Group of the Spanish Gastroenterological Association 2010World Journal of Gastroenterology2010,16,7:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费